Equities research analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their target price on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Analysis on MDRX
Veradigm Price Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- How Can Investors Benefit From After-Hours Trading
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Are Penny Stocks a Good Fit for Your Portfolio?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
